CIMM Steering Committee
Kunle Odunsi, MD, PhD
(2022-2024)Director;
Dean for Oncology, Biological Sciences Division
Professor of Obstetrics and Gynecology
University of Chicago Medicine Comprehensive Cancer Center
Chicago, Illinois
Catherine J. Wu, MD
(2023-2024)Professor of Medicine, Harvard Medical School
Chief, Division of Stem Cell Transplantation and Cellular Therapies
Dana-Farber Cancer Institute
Department of Medical Oncology
Lavine Family Chair for Preventative Cancer Therapies
Institute Member, Broad Institute of MIT and Harvard
Boston, Massachusetts
Ivan M. Borrello, MD
(2023-2026)Director
Multiple Myeloma, BMT and Cell Therapy
Tampa General Hospital
Tampa, Florida
Rostyslav Bilyy, PhD, DrSci
(2022-2025)Professor of Cytology, Histology & Embryology Department
Head of Immunology Laboratory
Danylo Halytsky Lviv National Medical University
Lviv, Ukraine
Lisa H. Butterfield, PhD
(2021-2024)Adjunct Professor of Microbiology and Immunology
University of California, San Francisco
San Francisco, California
John F. DiPersio, MD, PhD
(2023-2026)Virginia E. and Samuel J. Golman Professor of Medicine
Professor of Medicine and Pathology & Immunology
Director, Center for Gene and Cellular Immunotherapy
Washington University School of Medicine
St. Louis, Missouri
Kavita Dhodapkar, MBBS
(2021-2024)Professor of Pediatrics
Aflac Cancer and Blood Disorders Center
Children’s Hospital of Atlanta
Winship Cancer Institute
Emory University
Atlanta, Georgia
Jennifer L. Guerriero, PhD
(2023-2026)Assistant Professor, Harvard Medical School
Lead Investigator, Brigham and Women’s Hospital
Member, Breast Cancer, Dana-Farber/Harvard Cancer Center
Member, Harvard Immunology, Harvard Medical School
Boston, Massachusetts
Helen E. Heslop, MD
(2021-2024)Dan L. Duncan Chair
Director, Center for Cell and Gene Therapy
Baylor College of Medicine
Houston, Texas
Lawrence Fong, MD
(2022-2025)Efim Guzik Distinguished Professor in Cancer Biology
Leader, Cancer Immunotherapy Program
Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco
San Francisco, California
Sherene Loi, MD, PhD
(2022-2025)Professor, University of Melbourne
Consultant Medical Oncologist
Breast Unit Head, Translational Breast Cancer Genomics and Therapeutics Lab
Breast Stream Lead, Parkville Precinct Cancer Clinical Trials Unit
National Breast Cancer Foundation of Australia Endowed Chair
Peter MacCallum Cancer Centre
Melbourne, Australia
Marcela V. Maus, MD, PhD
(2021-2024)Director of Cellular Immunotherapy
Massachusetts General Hospital
Boston, Massachusetts
Jeffrey S. Miller, MD
(2023-2026)Professor of Medicine
Section Head, BMT and Cell Therapy
Division of Hematology, Oncology and Transplantation
Deputy Director, Masonic Cancer Center
Roger L. and Lynn C. Headrick Family Chair in Cancer Therapeutics
University of Minnesota
Minneapolis, Minnesota
Karolina Palucka, MD, PhD
(2023-2026)Professor
Director of the JAX Cancer Center
The Jackson Laboratory for Genomic Medicine
Farmington, Connecticut
Marco Ruella, MD
(2022-2025)Assistant Professor of Medicine
Scientific Director, Lymphoma Program
Division of Hematology and Oncology and Center for Cellular Immunotherapies
Perelman Center for Advanced Medicine
University of Pennsylvania,
Philadelphia, Pennsylvania
Takemasa Tsuji, PhD
(2021-2024)Research Associate Professor
Obstetrics and Gynecology-Gynecologic Oncology
University of Chicago
Chicago, Illinois
Jennifer A. Wargo, MD, MMSc
(2022-2025)Endowed Professor
Surgical Oncology and Genomic Medicine
Program Director for PRIME TR
University of Texas MD Anderson Cancer Center
Houston, Texas